A head patch device that delivers alternating ... current phase 3 data investigating paclitaxel treatment alone in recurrent ovarian cancer, Optune plus paclitaxel almost doubled progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback